Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Potenza – page 3

31 clinical trials in Potenza, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Potenza at a glance
31
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

31 trials in Potenza

Open in trial search

Follicular lymphoma

Not recruiting

Study Comparing Shortened vs Standard Chemotherapy with Rituximab for Initial Treatment of High Tumor Burden Follicular Lymphoma in Newly Diagnosed Patients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bendamustine
  • Sponsor:Fondazione Italiana Linfomi Ets

Back pain

Not recruiting

Study on the Effectiveness of Diclofenac Sodium and Thiocolchicoside in Relieving Acute Low Back Pain in Adults

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Diclofenac
  • Sponsor:Epifarma S.r.l.

Study on Avelumab for Patients with High-Risk Triple Negative Breast Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Universita Degli Studi Di Padova

Study on Prednisone and Vitamin D for Elderly Patients with Diffuse Large B-Cell Lymphoma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Colecalciferol
  • Sponsor:Fondazione Italiana Linfomi Ets

Cystic fibrosis

Not recruiting

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Deutivacaftor
  • Sponsor:Vertex Pharmaceuticals Inc.

Cystic fibrosis

Not recruiting

Long-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Elexacaftor
  • Sponsor:Vertex Pharmaceuticals Inc.

Study of Durvalumab and Regorafenib for Patients with Stage IV Colorectal Cancer with No Evidence of Disease

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:IRCCS Ospedale Policlinico San Martino

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Potenza

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials focusing on heart failure prevention and management of cardiac complications. Studies include evaluation of novel drug combinations and cardiac surgery interventions.

  • Heart Failure Prevention Studies
  • Complex Cardiac Surgery Management
  • Low Cardiac Output Syndrome Research

Cutting-edge research exploring combination therapies with medications like baxdrostat and dapagliflozin.

02 Oncology Studies

Comprehensive research in colorectal cancer, breast cancer, and lymphoma treatments, investigating novel therapeutic approaches and treatment combinations.

  • Metastatic Colorectal Cancer Therapies
  • Early-Stage Breast Cancer Treatments
  • Lymphoma Management Strategies

Advanced clinical trials evaluating biomarker-driven treatments and immunotherapy combinations.

03 Specialized Therapeutic Areas

Targeted research in cystic fibrosis and acute pain management, focusing on innovative treatment approaches and symptom relief.

  • Cystic Fibrosis Treatments
  • Back Pain Management
  • Emergency Medicine Interventions

Studies evaluating novel drug combinations and therapeutic strategies for chronic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.